Yara G Abdou (Yara Abdou)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 25

Top Topics

Locally Advanced

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah C Van Alsten, Matthew R Dunn, Alina M Hamilton, Joannie M Ivory, Xiaohua Gao, Erin L Kirk, Joseph S Nsonwu-Farley, Lisa Anne Carey, Yara G Abdou, Katherine E Reeder-Hayes, Mya L Roberson, Stephanie B Wheeler, Marc A Emerson, Terry Hyslop, Melissa A Troester
Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (5) (2024)
Sarah C Van Alsten, Matthew R Dunn, Alina M Hamilton, Joannie M Ivory, Xiaohua Gao, Erin L Kirk, Joseph S Nsonwu-Farley, Lisa Anne Carey, Yara G Abdou, Katherine E Reeder-Hayes, Mya L Roberson, Stephanie B Wheeler, Marc A Emerson, Terry Hyslop, Melissa A Troester
Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (5) (2024)
Jesse D Ortendahl, Gebra Cuyun Carter, Snehal G Thakkar, Katalin Bognar, David W Hall, Yara G Abdou
Value of next generation sequencing (NGS) testing in advanced cancer patients. Journal of medical economics 27 (1) (2024)
Francesco Schettini, Eva Blondeaux, Chiara Molinelli, Raphaëlle Bas, Hee Jeong Kim, Antonio di Meglio, Rinat Bernstein Molho, Sabine C Linn, Katarzyna Pogoda, Estela Carrasco, Kevin Punie, Elisa Agostinetto, Nerea Lopetegui Lia, Kelly-Anne Phillips, Angela Toss, Christine Rousset-Jablonski, Marion Acheritogaray, Alberta Ferrari, Shani Paluch-Shimon, Robert Fruscio, Wanda Cui, Stephanie M Wong, Claudio Vernieri, Maria Vittoria Dieci, Alexios Matikas, Mariya Rozenblit, Cynthia Villarreal Garza, De Marchis Laura, Fabio Puglisi, Leonor Vasconcelos de Matos, Monica Mariño, Luis Teixeira, Rossella Graffeo, Alessia Rognone, Alessandra Chirco, Nicoleta Antone, Yara G Abdou, Maximilian Marhold, Ivana Božović-Spasojević, Cortes Salgado Alfonso, Luca Carmisciano, Marco Bruzzone, Curigliano Giuseppe, Aleix Prat, Matteo Lambertini
Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study. Cancer (2024)
Prarthna V Bhardwaj, Yara G Abdou
Navigating Treatment Pathways in Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: Optimizing Second-Line Endocrine and Targeted Therapies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Sarah C Van Alsten, Matthew R Dunn, Alina M Hamilton, Joannie M Ivory, Xiaohua Gao, Erin L Kirk, Joseph S Nsonwu-Farley, Lisa Anne Carey, Yara G Abdou, Katherine E Reeder-Hayes, Mya L Roberson, Stephanie B Wheeler, Marc A Emerson, Terry Hyslop, Melissa A Troester
Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Sarah C Van Alsten, Matthew R Dunn, Alina M Hamilton, Joannie M Ivory, Xiaohua Gao, Erin L Kirk, Joseph S Nsonwu-Farley, Lisa Anne Carey, Yara G Abdou, Katherine E Reeder-Hayes, Mya L Roberson, Stephanie B Wheeler, Marc A Emerson, Terry Hyslop, Melissa A Troester
Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Sarah C Van Alsten, Matthew R Dunn, Alina M Hamilton, Joannie M Ivory, Xiaohua Gao, Erin L Kirk, Joseph S Nsonwu-Farley, Lisa Anne Carey, Yara G Abdou, Katherine E Reeder-Hayes, Mya L Roberson, Stephanie B Wheeler, Marc A Emerson, Terry Hyslop, Melissa A Troester
Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Erica L Mayer, Yue Ren, Nikhil Wagle, Reshma L Mahtani, Cynthia X Ma, Angela M DeMichele, Massimo Cristofanilli, Jane Meisel, Kathy D Miller, Yara G Abdou, Elizabeth C Riley, Rubina Qamar, Priyanka Sharma, Sonya A Reid, Natalie Sinclair, Meredith Faggen, Caroline C Block, Naomi Y Ko, Ann H Partridge, Wendy Y Chen, Michelle DeMeo, Victoria Attaya, Amanda Okpoebo, Jillian Alberti, Yuan Liu, Eric Gauthier, Harold J Burstein, Meredith M Regan, Sara M Tolaney
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jesse D Ortendahl, Gebra Cuyun Carter, Snehal G Thakkar, Katalin Bognar, David W Hall, Yara G Abdou
Value of next generation sequencing (NGS) testing in advanced cancer patients. Journal of medical economics 27 (1) (2024)
Francesco Schettini, Eva Blondeaux, Chiara Molinelli, Raphaëlle Bas, Hee Jeong Kim, Antonio di Meglio, Rinat Bernstein Molho, Sabine C Linn, Katarzyna Pogoda, Estela Carrasco, Kevin Punie, Elisa Agostinetto, Nerea Lopetegui Lia, Kelly-Anne Phillips, Angela Toss, Christine Rousset-Jablonski, Marion Acheritogaray, Alberta Ferrari, Shani Paluch-Shimon, Robert Fruscio, Wanda Cui, Stephanie M Wong, Claudio Vernieri, Maria Vittoria Dieci, Alexios Matikas, Mariya Rozenblit, Cynthia Villarreal Garza, De Marchis Laura, Fabio Puglisi, Leonor Vasconcelos de Matos, Monica Mariño, Luis Teixeira, Rossella Graffeo, Alessia Rognone, Alessandra Chirco, Nicoleta Antone, Yara G Abdou, Maximilian Marhold, Ivana Božović-Spasojević, Cortes Salgado Alfonso, Luca Carmisciano, Marco Bruzzone, Curigliano Giuseppe, Aleix Prat, Matteo Lambertini
Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study. Cancer 130 (16) (2024)
Sarah C Van Alsten, Matthew R Dunn, Alina M Hamilton, Joannie M Ivory, Xiaohua Gao, Erin L Kirk, Joseph S Nsonwu-Farley, Lisa Anne Carey, Yara G Abdou, Katherine E Reeder-Hayes, Mya L Roberson, Stephanie B Wheeler, Marc A Emerson, Terry Hyslop, Melissa A Troester
Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (5) (2024)
Jesse D Ortendahl, Gebra Cuyun Carter, Snehal G Thakkar, Katalin Bognar, David W Hall, Yara G Abdou
Value of next generation sequencing (NGS) testing in advanced cancer patients. Journal of medical economics 27 (1) (2024)
Sarah C Van Alsten, Matthew R Dunn, Alina M Hamilton, Joannie M Ivory, Xiaohua Gao, Erin L Kirk, Joseph S Nsonwu-Farley, Lisa Anne Carey, Yara G Abdou, Katherine E Reeder-Hayes, Mya L Roberson, Stephanie B Wheeler, Marc A Emerson, Terry Hyslop, Melissa A Troester
Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Erica L Mayer, Yue Ren, Nikhil Wagle, Reshma L Mahtani, Cynthia X Ma, Angela M DeMichele, Massimo Cristofanilli, Jane Meisel, Kathy D Miller, Yara G Abdou, Elizabeth C Riley, Rubina Qamar, Priyanka Sharma, Sonya A Reid, Natalie Sinclair, Meredith Faggen, Caroline C Block, Naomi Y Ko, Ann H Partridge, Wendy Y Chen, Michelle DeMeo, Victoria Attaya, Amanda Okpoebo, Jillian Alberti, Yuan Liu, Eric Gauthier, Harold J Burstein, Meredith M Regan, Sara M Tolaney
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Erica L Mayer, Yue Ren, Nikhil Wagle, Reshma L Mahtani, Cynthia X Ma, Angela M DeMichele, Massimo Cristofanilli, Jane Meisel, Kathy D Miller, Yara G Abdou, Elizabeth C Riley, Rubina Qamar, Priyanka Sharma, Sonya A Reid, Natalie Sinclair, Meredith Faggen, Caroline C Block, Naomi Y Ko, Ann H Partridge, Wendy Y Chen, Michelle DeMeo, Victoria Attaya, Amanda Okpoebo, Jillian Alberti, Yuan Liu, Eric Gauthier, Harold J Burstein, Meredith M Regan, Sara M Tolaney
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Prarthna V Bhardwaj, Yara G Abdou
The Evolving Landscape of Immune Checkpoint Inhibitors and Antibody Drug Conjugates in the Treatment of Early-Stage Breast Cancer. The oncologist (2023)
Zev M Nakamura, Allison M Deal, Eliza M Park, Kate E Stanton, Yesy E Lopez, Laura J Quillen, Erin O'Hare Kelly, Hillary M Heiling, Kirsten A Nyrop, Emily M Ray, E Claire Dees, Katherine E Reeder-Hayes, Trevor A Jolly, Lisa A Carey, Yara G Abdou, Oludamilola A Olajide, Julia K Rauch, Ranjit Joseph, Anureet Copeland, Megan A McNamara, Tim A Ahles, Hyman B Muss
A phase II single-arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effects. Cancer medicine (2023)
Prarthna V Bhardwaj, Yue Wang, Elizabeth Brunk, Philip M Spanheimer, Yara G Abdou
Advances in the Management of Early-Stage Triple-Negative Breast Cancer. International journal of molecular sciences 24 (15) (2023)
Yara G Abdou, Atta Goudarzi, Jia Xin Yu, Samik Upadhaya, Benjamin G Vincent, Lisa Anne Carey
Immunotherapy in triple negative breast cancer: beyond checkpoint inhibitors. NPJ breast cancer 8 (1) (2022)
Alina M Hamilton, Amber N Hurson, Linnea T Olsson, Andrea Walens, Joseph Nsonwu-Farley, Erin L Kirk, Yara G Abdou, Stephanie M Downs-Canner, Jonathan S Serody, Charles M Perou, Benjamin C Calhoun, Melissa A Troester, Katherine A Hoadley
The Landscape of Immune Microenvironments in Racially Diverse Breast Cancer Patients. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31 (7) (2022)
Prarthna V Bhardwaj, Yara G Abdou
Germline Genetic Testing in Breast Cancer: Systemic Therapy Implications. Current oncology reports 24 (12) (2022)
Yara G Abdou, Manu Pandey, Maithreyi Sarma, Shrunjal Shah, Jeffrey Baron, Marc S Ernstoff
Mechanism-based treatment of cancer with immune checkpoint inhibitor therapies. British journal of clinical pharmacology 86 (9) (2020)
Maithreyi Sarma, Yara G Abdou, Ajay Dhakal, Shipra Gandhi
Significance of the Genomic Landscape of a De Novo Endocrine-Resistant Metastatic Hormone Receptor-Positive Breast Cancer. Breast cancer : basic and clinical research 14 (2020)
Yara G Abdou, Ahmed Elkhanany, Kristopher Attwood, Wenyan Ji, Kazuaki Takabe, Mateusz Opyrchal
Primary and secondary breast angiosarcoma: single center report and a meta-analysis. Breast cancer research and treatment 178 (3) (2019)